Barreda Moller writes...

Pharmaceutical patent, generic pharmaceuticals and bioequivalence

The invention patent has a 20-year term, counted from the filing date of the respective application for registration, once it is granted. The patent grants its owner the exclusive right [...]

Type of characteristic that descriptive marks should describe to be irregistrable

Article 135, paragraph e) of Decision 486, Industrial Property Common Regime, establishes that may not be registered as trademarks those marks which consist exclusively of a sign or statement that [...]

Binding nature of the declaration of “notoriety” of a trademark in one of the member countries of the Andean Community

Decision 486 establishes in Article 224 that notoriously known distinctive sign shall mean the sign that is recognized as such in any member country, by the pertinent sector, regardless the [...]

Registration of proper names

Traditionally, the trademark Authority has established that the indirect confusion between two signs is determined by the coincidence of one of their elements –provided the coincident element is distinctive and [...]